AzTrials
AzTrials

Acute Respiratory Failure (ARF)MusiNIVNCT06848218

Music Therapy During NIV Implantation in Pediatric Intensive Care Units

A study testing Music Therapy and Setting Up NIV in people with Acute Respiratory Failure (ARF) and Non Invasive Ventilation (NIV), run by University Hospital, Montpellier at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Non-invasive ventilation makes it possible to avoid intubation and improve patients' quality of life. However, pain is associated with discomfort and could lead to failure of this technique. Read more about this study

Who is it for?
Ages Up to 17 years
What is being tested?
Music Therapy and Setting Up NIV
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
88 participants
Where
1 siteFrance
Study dates
18 Jun 2025to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 0 to 17 inclusive
  • Children hospitalized in pediatric intensive care unit
  • Indication for NIV

Who cannot join

  • - Severe deafness
  • Clinical condition requiring immediate initiation of NIV
  • Refusal to allow the child to be photographed
  • Child not assessable by FLACC score (paralysis of lower limbs, etc.)
  • Child already receiving NIV respiratory support at home
  • Participation in other ongoing research involving the human person at major risk and constraint (RIPH category 1) or a drug trial according to European regulation 536/2014.
Show all 9Show fewer
  • Absence of affiliation to a French social security scheme or beneficiary of such a scheme.
  • Subject deprived of liberty (art.L. 1121-6 du CSP)
  • Failure to obtain free and informed written or oral consent and authorization to take photographs from both parents (or from a single parent if the patient is accompanied by only one parent, in accordance with article 1122-2 of the French Public Health Code) or from the legal guardian and/or child.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU de MONTPELLIER

    Montpellier, 34090

    s-mounier@chu-montpellier.fr

    Recruiting

Other trials in France

About this study

Non-invasive ventilation makes it possible to avoid intubation and improve patients' quality of life. However, pain is associated with discomfort and could lead to failure of this technique.

The aim of this study is to measure the effectiveness of music therapy on pain levels during non-invasive ventilation in critically ill children.

To this end, a pain score (Face Legs Activity Cry Consolability FLACC) will be assessed by raters blinded to the randomization arm during NIV initiation.

The FLACC score will be compared before and during implementation of NIV between two groups: a control group (without music therapy) and an experimental group (with music therapy).

Read the detailed description

Patient admitted to a Pediatric Intensive Care Unit are exposed to moderate to severe pain due to disease severity and invasive treatment or procedures.

Non invasive ventilation is an essential support in the treatment of infants and children with acute respiratory failure. Acceptance and tolerance are the keys to its success.

Comfort management, including pain management, is most often achieved through the administration of analgesic and/or sedative drugs (analgesics, anti-inflammatories, anxiolytics, hypnotics). However, these therapies, although effective, are not without risks, including potentially serious adverse effects (excessive sedation, prolonged hospitalization and ventilation, tolerance phenomena, withdrawal syndrome, delirium, constipation, etc.). These undesirable effects and their deleterious consequences prompt a more comprehensive approach to patient management, optimizing therapeutic strategies with the common aim of improving patient comfort and pain relief. One specific program, "Music Care" is based on a "U sequence" which use tempo and rhythm variations following the U scheme, to relax patients.

This program will be evaluated in the pediatric intensive care department and the investigators will study the effects on the pain level during a non invasive ventilation setting for children with respiratory failure.

the investigators will compare the variation of the FLACC scores (before and during nopn invasive ventilation setting) to show a difference between both methods. The order (with or without) will be randomized.

Being tested
Music Therapy, Setting Up NIV
Keywords
Music Therapy, Non invasive Ventilation, Pediatric intensive care unit, Pain, Comfort
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music TherapyOther

    This procedure is carried out using headphones installed in the child's ears. The music will be activated if the child is in the Music group, and will not be activated but present if the child is not in the Music group.

    NIV implementation will begin after 10 min of listening. The listening period will continue until the nadir period (when the music is slowest, for maximum relaxation), until 10 min after the start of the NIV.

  • Setting Up NIVProcedure or surgery

    Non invasive ventilation is set up in several stages, with the help of at least two caregivers. The patient will be placed in a half-seated position or seated. Installation begins with the placement of the non invasive ventilation mask harness around the child's head, followed by the application of the mask to the face, held by a caregiver. Once the mask has been applied, ventilation is started by connecting the non invasive ventilation circuit to the mask. The harness is then tightened by the second caregiver.

Study groups in NCT06848218
Study groupRoleWhat they receive
Non invasive ventilation setting with Music TherapyExperimentalEach child will benefit non invasive ventilation setting for acute respiratory distress. In this group, it will be with Music Therapy. Every time, the preparation will be the same with equipment installation with headphones for music listening, in order to keep comparability and blind for the evaluation. Sound will be activated in this group. Each child will be videotaped during the non invasive ventilation setting.
Receives: Other: Music Therapy; Procedure: Setting Up NIV
Non invasive ventilation setting without Music TherapySham comparatorEach child will benefit Non invasive ventilation setting for acute respiratory distress. In this group, it will be without Music therapy. Every time, the preparation will be the same with equipment installation with headphones for music listening, in order to keep comparability and blind for the evaluation. Sound will not be activated in this group. Each child will be videotaped during the non invasive ventilation setting.
Receives: Procedure: Setting Up NIV

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain variation before and during non invasive ventilation setting with and without music therapy.

    FLACC (Face Legs Activity Cry Consolability) : The main assessment tool is a simple, rapid behavioral pain assessment scale, commonly used in the pediatric intensive care unit.

    For each item, 3 possible scores: 0 or 1 or 2; the total score is from 0 (no pain) to 10 (severe pain).

    The primary outcome is variation of the Face Legs Activity Cry Consolability (FLACC) score (range, 0-10) comparing before and during non invasive ventilation setting.

    The first FLACC score evaluation will be just before the beginning of music. The Second FLACC score evaluation will be during the non invasive ventilation setting.

    FLACC score evaluation over a 10-minute period, with selection of the highest score for each item during the evaluation period FLACC scores' evaluation will be done from videotape records without by 2 investigators The FLACC score will be determined blindly by two assessors who did not participate in the care, using the video taken when the NIV was set up.

    Measured: assessment for 10 minutes before NIV start-up and for 10 minutes during NIV installation

Secondary outcomes (14)
  1. Pain variation during and after non invasive ventilation setting with and without music therapy. the highest score for each parameter will be selected for each evaluation period of 10 minutes

    FLACC (Face Legs Activity Cry Consolability) : The main assessment tool is a simple, rapid behavioral pain assessment scale, commonly used in the pediatric intensive care unit.

    For each item, 3 possible scores: 0 or 1 or 2; the total score is from 0 (no pain) to 10 (severe pain).

    The primary outcome is variation of the Face Legs Activity Cry Consolability (FLACC) score (range, 0-10) comparing before and during non invasive ventilation setting.

    The first FLACC score evaluation will be just before the beginning of music. The Second FLACC score evaluation will be during the non invasive ventilation setting.

    FLACC scores' evaluation will be done from videotape records without by 2 investigators

    The FLACC score will be determined blindly by two assessors who did not participate in the care, using the video taken when the NIV was set up.

    Measured: assessment for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  2. Physiological data variations between the 2 groups: HR

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    HR: heart rate in beats per minute the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  3. Physiological data variations between the 2 groups: FR

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    FR: respiratory rate in inhalations per minute the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  4. Physiological data variations between the 2 groups: SBP

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    SBP: systolic blood pressure in millimeters of mercury mmHg the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  5. Physiological data variations between the 2 groups: MAP

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    MAP: mean arterial pressure in millimetres of mercury mmHg the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  6. Physiological data variations between the 2 groups: SpO2

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    SpO² : blood oxygen saturation in percent the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  7. Physiological data variations between the 2 groups: FiO2.

    An initial reading will be taken 10 minutes before NIV start-up, during start-up and 10 minutes afterwards.

    FiO2: fraction of inspired oxygen in percent the highest score for each parameter will be selected for each evaluation period of 10 minutes

    Measured: assessment for 10 minutes before NIV start-up, for 10 minutes during NIV installation and for 10 minutes after NIV start-up

  8. NIV set-up time between groups

    time from initiation to completion of NIV installation in minutes

    Measured: from initiation to completion of NIV installation

  9. Total NIV duration between groups

    in hours

    Measured: From initiation of the first NIV to the date of death or discharge from hospital, or up to 1 month after initiation of the NIV at the most

  10. Failure to implement NIV between groups

    in raw numbers

    Measured: From initiation of the first NIV to the date of death or discharge from hospital, or up to 1 month after initiation of the NIV at the most

  11. Use of sedative or anxiolytic drugs during NIV implantation between groups

    dose in μg/kg/h

    Measured: from initiation to completion of NIV installation

  12. Length of stay in intensive care between groups

    in days

    Measured: from the date of admission in intensive care until discharge, or up to 1 month after initiation of NIV

  13. total length of hospital stay between groups

    in days

    Measured: from the date of admission to hospital until discharge, or up to 1 month after initiation of NIV

  14. comparison of the number of NIV-related complications between the 2 groups

    Number of Complications of NIV, e.g. pneumothorax, decreased cardiac output (hypotension), gastric and abdominal distension, inhalation, nose, face and scalp pressure points, non-compliance, eye irritation

    Measured: from the date of admission to hospital until discharge, or up to 1 month after initiation of NIV

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2025
  2. Study start18 Jun 2025
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective, single-center, randomized controlled study, with blinded assessment of primary endpoint.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
88 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06848218
Sponsor's protocol ID
RECHMPL23_0191
Acronym
MusiNIV
Status last verified
Jun 2025
First submitted
23 Jan 2025
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Music Therapy and Setting Up NIV in people with Acute Respiratory Failure (ARF) and Non Invasive Ventilation (NIV), run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sophie MOUNIER, MD (04 67 33 66 09 ext. +33, s-mounier@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain variation before and during non invasive ventilation setting with and without music therapy. (time frame: assessment for 10 minutes before NIV start-up and for 10 minutes during NIV installation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in